MetaCap

First Tracks Biotherapeutics Insider Trades

NASDAQ: TRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

31.85-0.16 (-0.50%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
2 · $66.76M
Shares bought / sold
0 / 4.74M
Net activity
Net selling $66.8 million

First Tracks Biotherapeutics insider activity

Over the last 12 months, First Tracks Biotherapeutics insiders reported 11 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $66.8 million worth of stock, for net insider selling of $66.8 million. The largest seller was EcoR1 Capital, LLC, with $65.0 million in reported sales.

The most recent filing shows Orwin John A (Director) reporting a transaction in 1,300 shares on Sep 15, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TRAX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TRAX insider transactions

First Tracks Biotherapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 15, 2026Orwin John ADirectorOption exercise1,300—Form 4
Sep 2, 2026Ware J. AnthonyDirectorSale39,265$1.76MForm 4
Sep 2, 2026Ware J. AnthonyDirectorOption exercise39,265$225.38KForm 4
Jun 15, 2026FENTON DENNIS MDirectorOption exercise6,030—Form 4
Jun 15, 2026Marquet MagdaDirectorOption exercise6,030—Form 4
Jun 15, 2026Orwin John ADirectorOption exercise6,030—Form 4
Jun 15, 2026Ware J. AnthonyDirectorOption exercise6,030—Form 4
Jun 15, 2026Schmid John P.DirectorOption exercise6,030—Form 4
Jun 15, 2026Jain RitaDirectorOption exercise7,330—Form 4
Apr 20, 2026ANAPTYSBIO, INC10% Ownerother100—Form 4
Apr 20, 2026EcoR1 Capital, LLC10% OwnerSale4,705,575$65.00MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related